Mandatory rebates and clawbacks feature at GREEK industry/government meeting

It was emphasized that pharmaceutical spending is obviously insufficient and does not meet the real needs of the GREEK population, while the excess ...

READ THE ORIGINAL POST AT www.thepharmaletter.com